Lansoprazol Bluepharma (Lansoprazole)

Lansoprazole acts on the gastric proton pump to lower acid secretion, making it useful for several acid‑related disorders.

• Gastro‑oesophageal reflux disease (GERD): reduces acid exposure and promotes healing of the esophageal lining.
• Erosive esophagitis: facilitates mucosal repair and symptom relief.
• Peptic ulcer disease: supports ulcer healing by decreasing gastric acidity.
• Helicobacter pylori eradication (in combination therapy): enhances the effectiveness of antibiotic regimens by creating a less acidic environment.

• Lansoprazole irreversibly binds to the H+/K+ ATPase enzyme (the gastric proton pump) located on the secretory surface of parietal cells. By inhibiting this final step of acid production, it markedly reduces both basal and stimulated gastric acid secretion, leading to an increase in gastric pH and allowing damaged mucosa to heal.

Lansoprazole may cause a range of adverse reactions, from mild to serious.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhea: usually self‑limiting.
• Nausea: occasional, may improve with food.
• Abdominal pain: discomfort in the upper abdomen.
• Flatulence: increased gas production.
• Constipation: reduced bowel movements.

Serious or Rare Side Effects

• Severe allergic reaction (anaphylaxis): swelling, difficulty breathing.
• Clostridioides difficile infection: severe diarrhea, colitis.
• Elevated liver enzymes: signs of hepatic stress.
• Hypomagnesemia: low magnesium levels with prolonged use.
• Stevens‑Johnson syndrome: severe skin rash and mucosal involvement.
• Interstitial nephritis: kidney inflammation presenting with reduced urine output.

Before initiating therapy, consider the following safety measures.

• Assess renal function: adjust use in severe renal impairment.
• Monitor magnesium levels: prolonged therapy may cause hypomagnesemia.
• Avoid in known hypersensitivity: discontinue if allergic reaction occurs.
• Use caution in elderly patients: higher risk of fractures and bone loss.
• Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Lansoprazole can affect the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid)

• Clopidogrel: reduced antiplatelet effect.
• Atorvastatin: increased statin plasma concentrations.
• Methotrexate: heightened risk of toxicity.

Moderate Interactions (Monitor Closely)

• Warfarin: possible alteration of INR values.
• Digoxin: potential increase in serum digoxin levels.
• Diazepam: enhanced sedative effect.